IV iron for children with low iron anemia
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial studies IV ferric derisomaltose to treat iron deficiency anemia in children under 18. It is meant for children whose anemia is from a true iron problem and who either cannot tolerate or do not respond to iron taken by mouth, or have certain kidney-related causes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child must be under 18 years old
- Must have signed consent (and your child’s assent if required) before any trial steps
- Blood tests must show iron deficiency anemia: low hemoglobin for age/sex
- Either iron deficiency from certain causes (including gut problems or kidney-related issues), or known poor response/intolerance to iron taken by mouth
- For kidney-related cases: kidney function must be reduced and iron levels must meet specific cutoffs
- Certain safety limits apply: not too much iron stored, and key liver tests must not be more than 2x normal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two iron medicines—one a simple iron pill and the other a gentle iron form—to see which works better for children with low iron levels (anemia). If your child has iron deficiency anemia and none of the listed health issues, they may be able to join.
This study compares two intravenous iron treatments to see if one works as well as the other in people with iron deficiency anemia. It may help improve your iron levels and reduce anemia symptoms.
This study compares two IV iron treatments—ferumoxytol and iron sucrose—to treat iron deficiency anemia in children with chronic kidney disease. It aims to see which option works better and is safe, and also to learn how each medicine behaves in the body.
This trial tests ferumoxytol, an intravenous iron medicine, to treat iron deficiency anemia in children who cannot take or did not respond well to iron by mouth. It aims to improve blood iron levels and anemia symptoms safely.
This trial tests an iron infusion called ferric carboxymaltose to treat iron deficiency anemia in children and teens seen in the emergency department. It aims to improve their hemoglobin levels and overall health.
This trial studies whether taking iron by mouth can improve iron levels and anemia (low red blood cell counts) in children with chronic kidney disease. It may help reduce fatigue and support normal blood-making, by comparing different approaches for children who meet specific iron test results.
Hear when a new Iron Deficiency, Anaemia in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.